论文部分内容阅读
观察康复新液联合散结镇痛胶囊对浆细胞乳腺炎手术后病情恢复的影响及对机体免疫指标的改善情况。2011年2月~2013年10月,将136例在张家口市第一医院确诊为浆细胞乳腺炎的患者分为康复新液联合散结镇痛胶囊治疗组(67例)和泼尼松治疗对照组(69例),对比两组的治疗效果,同时监测免疫指标的变化。与对照组比较,治疗组术后的乳房疼痛、切口内渗液量的变化、切口完全愈合的时间有显著差异;与对照组比较,治疗组各项免疫指标的下降幅度亦有显著差异。康复新液联合散结镇痛胶囊口服,能促进浆细胞乳腺炎术后病情的恢复,提高机体免疫功能,值得临床推广。
To observe the effects of Kangfuxin Solution combined with Sanjiezhitong Capsule on the recovery of post-operative plasma cell mastitis and the improvement of immune indexes. From February 2011 to October 2013, 136 patients diagnosed as plasma cell mastitis in the First Hospital of Zhangjiakou City were divided into Kangfuxinye combined with Sanjiezhitong capsule group (67 cases) and prednisone control group (69 cases). The therapeutic effects of the two groups were compared, and the changes of immune indexes were monitored. Compared with the control group, the postoperative breast pain in the treatment group, the change of the amount of liquid in the incision, and the complete healing time of the incision were significantly different. Compared with the control group, the decline of various immunological indexes in the treatment group was also significantly different. Kangfuxin solution combined with Sanjie analgesic capsules can promote the recovery of plasma cell mastitis after operation and improve the immune function of the body, worthy of clinical promotion.